Cancer therapy-focused Nuvalent files for $100M IPO

Targeted cancer therapy is a type of cancer treatment that focuses on a specific area of Nuvalent has filed for a $100 million initial public offering (IPO), with the goal of trading on the Nasdaq under the symbol “NUVL.”/nRead More